Featured
The Biological Enclosure: Biotech Monopolies, Regulatory Moats, and the Death of the Wholesale Beauty Counter
L'Oréal’s $3.2 billion acquisition of SynthSkin Bio, the FDA’s CITAS mandate, and the Sephora-Ulta closed-loop retail joint venture mark the defi...
Read Full Story →